Biblio

Author Title Type [ Year

]

Filters: Author is Burke, Michael J [Clear All Filters]

2016

Burke MJ. Minimal Residual Disease in NPM1-Mutated AML. N Engl J Med. 2016.

2018

Andolina JR, Burke MJ, Hijiya N, Chaudhury S, Schultz KR, Roth ME. Practice Patterns of Physician Treatment for Pediatric Chronic Myeloid Leukemia (CML). Biol Blood Marrow Transplant. 2018.

2019

Taraseviciute A, Broglie L, Phelan R, Bhatt NS, Becktell K, Burke MJ. What is the Role of Hematopoietic Cell Transplantation (HCT) for Pediatric Acute Lymphoblastic Leukemia (ALL) in the Age of Chimeric Antigen Receptor T-Cell (CART) Therapy?. J Pediatr Hematol Oncol. 2019.

2022

Pommert L, Schafer ES, Malvar J, Gossai N, Florendo E, Pulakanti K, Heimbruch K, Stelloh C, Chi Y-Y, Sposto R, et al. Decitabine and Vorinostat with FLAG Chemotherapy in Pediatric Relapsed/Refractory AML: Report from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium. Am J Hematol. 2022.